Harbinger Health Introduces RESOLVE for Multi-Cancer Detection

April 14, 2026
Harbinger Health has announced RESOLVE, a new category of blood-based multi-cancer detection tests aimed at reducing diagnostic delays and improving clinical decision-making, with commercial availability expected in late 2026.

Cambridge-based Harbinger Health has announced RESOLVE, a new category of blood-based multi-cancer detection tests, according to a press release. The product line aims to address the period between cancer suspicion and diagnosis, with commercial availability planned for the second half of 2026.

The RESOLVE tests are powered by the Harbinger HX platform and are designed to reduce both false negatives and false positives while providing information about the cancer’s tissue of origin. The company stated that these features could enable faster clinical decision-making when cancer is suspected.

Development of the RESOLVE portfolio is supported by a $100 million financing round completed in 2025, led by Flagship Pioneering and existing investors. The funding also supports Harbinger’s ongoing PROCARES prospective validation study and further advancement of the HX platform.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

04/14
Sunbound Launches AI-First Revenue OS for Senior Living
04/14
Caristo Diagnostics Names Stephen Deitsch as CEO
04/14
Briya Expands Global Health Data Network to 120 Million Patient Journeys
04/14
Spirographic AI Launches Tissue-Specific Drug Target Prediction Platform
04/14
Tuesday Health Partners with Humana to Expand Palliative Care Access in Texas

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like